Clinical Trials Sponsored by Scandinavian Critical Care Trials Group

Total 513 results

Scandinavian Critical Care Trials Group

Terminated

Scandinavian Intensive Care Unit (ICU) Glutamine Study

ICU Patients

Sweden
Scandinavian Critical Care Trials Group

Not yet recruiting

Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis (EMPRESS)

Sepsis | Septic Shock

Denmark
Scandinavian Critical Care Trials Group

Completed

Does Rocking Charis Calm Delirious Patients in the Intensive Care Unit (RocingICU)

Delirium

Denmark
Anders Perner

Completed

Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care (CLASSIC)

Sepsis | Septic Shock

Denmark, Finland
Scandinavian Critical Care Trials Group
Rigshospitalet, Denmark; University of Copenhagen; Copenhagen Trial Unit, Center...

Completed

Transfusion-requirements in Septic Shock Trial (TRISS)

Septic Shock

Sweden, Norway, Finland, Denmark
Dr. Morten Hylander Møller
Rigshospitalet, Denmark; Copenhagen Trial Unit, Center for Clinical Intervention...

Completed

Stress Ulcer Prophylaxis in the Intensive Care Unit (SUP-ICU)

Gastrointestinal Bleeding | Stress Ulcers

Denmark, Netherlands, Switzerland, Norway, Finland, United Kingdom
Anders Perner
Rigshospitalet, Denmark; Scandinavian Critical Care Trials Group; Centre for...

Active, not recruiting

The Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care Trial (CLASSIC)

Septic Shock

Sweden, Denmark, Belgium, Czechia, Italy, Norway, Switzerland, United Kingdom
Scandinavian Critical Care Trials Group
Aarhus University Hospital; Rigshospitalet, Denmark; University of Copenhagen; Copenhagen...

Completed

Hydrocortisone for COVID-19 and Severe Hypoxia (COVID STEROID)

Covid-19 | Hypoxia

Denmark
Canadian Critical Care Trials Group
Canadian Intensive Care Foundation

Terminated

The Effect of High Frequency Oscillation on Biological Markers of Lung Injury

Acute Respiratory Distress Syndrome

Canada
Anders Perner
Rigshospitalet, Denmark; University of Copenhagen; B. Braun Melsungen AG; Copenhagen...

Completed

Scandinavian Starch for Severe Sepsis/Septic Shock Trial (6S)

Septic Shock | Severe Sepsis

Denmark, Norway, Finland, Iceland
Niklas Nielsen
Lund University; The George Institute for Global Health, Australia; Copenhagen... and other collaborators

Completed

Target Temperature Management After Cardiac Arrest (TTM)

Out-of-hospital Cardiac Arrest

Sweden, Netherlands, Norway, United Kingdom, Italy, Australia, Switzerland, Luxembourg, Czech Republic, Denmark
NCIC Clinical Trials Group

Completed

Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

Breast Cancer

Canada
NCIC Clinical Trials Group

Completed

Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer

Head and Neck Cancer

Canada
NCIC Clinical Trials Group

Terminated

Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer

Liver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct Cancer

Canada
NCIC Clinical Trials Group

Completed

Radiation in Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Lung Cancer

Canada
NCIC Clinical Trials Group

Terminated

BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer

Bladder Cancer

Canada
NCIC Clinical Trials Group

Completed

Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer

Prostate Cancer

Canada
NCIC Clinical Trials Group

Completed

Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

Canada, Singapore, Australia, Romania, Argentina, Brazil
NCIC Clinical Trials Group

Completed

OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors

Kidney Cancer | Breast Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Bladder Cancer
NCIC Clinical Trials Group

Completed

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

Breast Cancer

Canada
NCIC Clinical Trials Group

Completed

Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Prostate Cancer

United States, Canada
NCIC Clinical Trials Group

Completed

AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)

Colorectal Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific

Canada
NCIC Clinical Trials Group

Completed

Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme

Brain and Central Nervous System Tumors

Canada
NCIC Clinical Trials Group

Completed

AEG35156 and Docetaxel in Treating Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Canada
NCIC Clinical Trials Group

Completed

Topotecan in Treating Patients With Recurrent Brain Tumors

Brain and Central Nervous System Tumors

Canada
NCIC Clinical Trials Group

Completed

Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer

Quality of Life | Pain | Fatigue | Lung Cancer | Pulmonary Complications | Nausea and Vomiting

Canada
NCIC Clinical Trials Group

Completed

Treatment for Chronic Pain in Patients With Advanced Cancer

Pain | Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous/Nonmalignant Condition

Canada
NCIC Clinical Trials Group

Completed

Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung Cancer

Lung Cancer

Canada
NCIC Clinical Trials Group

Completed

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Cancer

Canada
NCIC Clinical Trials Group

Completed

Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia

Prostate Cancer | Precancerous/Nonmalignant Condition

Canada
NCIC Clinical Trials Group

Completed

Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

Canada, Brazil
NCIC Clinical Trials Group

Completed

Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma

Lymphoma

Canada
NCIC Clinical Trials Group

Completed

Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3

Breast Cancer | Osteoporosis

United States, Canada
NCIC Clinical Trials Group

Completed

Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

Canada
NCIC Clinical Trials Group

Completed

AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer

Colorectal Cancer | Lung Cancer

Canada
NCIC Clinical Trials Group

Completed

OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer

Breast Cancer

Canada
NCIC Clinical Trials Group

Completed

AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Canada
NCIC Clinical Trials Group

Completed

Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma

Lymphoma

Canada
NCIC Clinical Trials Group

Completed

SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Colorectal Cancer

Canada
NCIC Clinical Trials Group

Completed

Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Sarcoma

Canada, United States
NCIC Clinical Trials Group

Completed

Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx

Head and Neck Cancer | Oral Complications

Canada
NCIC Clinical Trials Group

Completed

Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

Canada, United Kingdom
NCIC Clinical Trials Group

Completed

Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer

Endometrial Cancer
NCIC Clinical Trials Group

Completed

Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer

Lung Cancer

United States, Spain, Canada, Italy, France, Switzerland, Netherlands, Belgium, Germany, Finland, United Kingdom, Poland, Portugal, Austria
NCIC Clinical Trials Group

Completed

ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Prostate Cancer

Canada
NCIC Clinical Trials Group

Completed

Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery

Endometrial Cancer

Canada, United States, Australia
NCIC Clinical Trials Group

Completed

MG98 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States, Canada
NCIC Clinical Trials Group

Completed

Theophylline in Treating Cancer Patients With Shortness of Breath

Quality of Life | Unspecified Adult Solid Tumor, Protocol Specific | Pulmonary Complications

Canada
NCIC Clinical Trials Group

Completed

Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer

Breast Cancer

United States, Canada
NCIC Clinical Trials Group

Completed

Combination Chemotherapy in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

Canada, United States

Clinical Trials Sponsored by Scandinavian Critical Care Trials Group

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations